<DOC>
	<DOCNO>NCT01601652</DOCNO>
	<brief_summary>The study evaluate safety efficacy intravenous fish oil emulsion ( omegaven ) infant parenteral nutrition associate cholestasis .</brief_summary>
	<brief_title>Compassionate Use Intravenous Fish Oil Emulsion Infants With Cholestasis</brief_title>
	<detailed_description />
	<mesh_term>Cholestasis</mesh_term>
	<criteria>Cholestasis define either serum bilirubin &gt; 2mg/dL ( two measurement least 8d apart ) respond 4 week intralipid reduce 1 g/kg/d trace mineral limit twice weekly , OR serum bilirubin &gt; 6 mg/dL ( single measurement ) rising , absence proven suspect sepsis Age &gt; 1y time omegaven start Not expect survive least 30 day Fish allergy first degree relative Hemodynamic instability Coagulopathy Not likely require PN &gt; 30d Not expect survive &gt; 30d</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cholestasis</keyword>
	<keyword>PNAC</keyword>
	<keyword>Parenteral Nutrition Associated Cholestasis</keyword>
	<keyword>PNALD</keyword>
	<keyword>Parenteral Nutrition Associated Liver Disease</keyword>
</DOC>